Effects of recombinant human growth hormone on enterocutaneous fistula patients

doi:10.3748/wjg.14.6858

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 14, Issue 44

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (2775)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-1) series, Tables (1-3) series.

Item

Count

PDF

233

HTML

2161

Figures (1-1)

176

Tables (1-3)

205

Sum=2775

Nov 28, 2008 (publication date) through Nov 26, 2024

Times Cited of This Article

Times Cited (5)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Rapid Communication

World J Gastroenterol. Nov 28, 2008; 14(44): 6858-6862
Published online Nov 28, 2008. doi: 10.3748/wjg.14.6858

Open in New Tab Full Size Figure Download Figure

Figure 1 Villus height and proliferative activity. Significant improvements occurred in villus heights and in the expression of PCNA on the intestinal mucosal epithelial cells at day 4 and 7 (P < 0.01). A: Villus heights; B: PCNA labelling index.

Citation: Gu GS, Ren JA, Li N, Li JS. Effects of recombinant human growth hormone on enterocutaneous fistula patients. World J Gastroenterol 2008; 14(44): 6858-6862
URL: https://www.wjgnet.com/1007-9327/full/v14/i44/6858.htm
DOI: https://dx.doi.org/10.3748/wjg.14.6858